GlaxoSmithKline PLC Director/PDMR Shareholding (3902X)
18 Dicembre 2019 - 05:55PM
UK Regulatory
TIDMGSK
RNS Number : 3902X
GlaxoSmithKline PLC
18 December 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA')
==== ==============================================================================================
a) Name Mr R Simard
==== ======================================= =====================================================
b) Position/status President, Pharmaceuticals Supply Chain
==== ======================================= =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================= =====================================================
b) Nature of the Following the final vesting on 16 December
transaction 2019 of an award made on 13 December 2013
under the GlaxoSmithKline Deferred Investment
Award programme, Mr Simard will receive
a cash payment of GBP60,237.79 less applicable
tax withholding in respect of 3,414.453
notional Ordinary Shares.
==== ======================================= =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ========================== ======================
GBP17.642 3,414.453
======================================================================= ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
==================================================================== =============================
e) Date of the transaction 2019-12-16
==== ======================================= =====================================================
f) Place of the N/A
transaction
==== ======================================= =====================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHQVLFFKLFEFBZ
(END) Dow Jones Newswires
December 18, 2019 11:55 ET (16:55 GMT)
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2023 a Mar 2024